IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out

Published on 10 Jan 2025 on Market Watch

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to...

Read the rest of the article

Start tracking your investments with Statfolio

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.66%

Investing.com 11 Jan 2025

Market cap stock movers: Oracle, Netflix slide on Friday

Investing.com 11 Jan 2025

IGM Biosciences is again cutting staff as it scraps an autoimmune-drug trial after failing to...

Market Watch 10 Jan 2025

Add two more Bay Area life sciences companies to the list of those cutting jobs after a 9%...

The Business Journals 10 Jan 2025

Key Insights IGM Biosciences' Annual General Meeting to take place on 11th of June Salary of...

Simply Wall St. · via Yahoo Finance 23 May 2024

IGM Biosciences, Inc. (IGMS) came out with a quarterly loss of $0.83 per share versus the Zacks C...

Zacks via Yahoo Finance 9 May 2024

Revenue: Reported Q1 2024 collaboration revenue of $0.5 million, falling short of the estimated $...

GuruFocus.com via Yahoo Finance 8 May 2024

Wall Street expects a year-over-year increase in earnings on higher revenues when IGM Biosciences...

Zacks via Yahoo Finance 3 May 2024

Over the last year, a good number of insiders have significantly increased their holdings in IGM ...

Simply Wall St. via Yahoo Finance 19 Apr 2024

In recent trading activity, Steven Weber, the Principal Accounting Officer of IGM Biosciences, In...

Investing.com 16 Mar 2024